Browse Category

Company News News 6 December 2025 - 8 December 2025

Warner Bros. Discovery (WBD) Stock Before the Bell: What to Know on December 8, 2025 After Netflix’s $82.7 Billion Bid

Warner Bros. Discovery (WBD) Stock Before the Bell: What to Know on December 8, 2025 After Netflix’s $82.7 Billion Bid

Warner Bros. Discovery, Inc. Series A common stock (NASDAQ: WBD) heads into Monday’s U.S. session as one of the market’s most closely watched merger-arbitrage trades rather than a conventional media turnaround story. On Friday, WBD closed at $26.08, up roughly
KSS Stock Outlook 2025: Kohl’s Turnaround Story, Latest News, Forecasts and Analysis as of December 7, 2025

KSS Stock Outlook 2025: Kohl’s Turnaround Story, Latest News, Forecasts and Analysis as of December 7, 2025

Kohl’s Corporation (NYSE: KSS) has turned into one of 2025’s most unpredictable retail stocks. After a brutal start to the year and a “meme‑stock‑style” summer spike, the shares are now trading near their 52‑week highs following a surprise profit, a
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Updated: December 7, 2025 Merck & Co., Inc. (NYSE: MRK) — the U.S. pharmaceutical company behind blockbuster cancer drug Keytruda and HPV vaccine Gardasil — has just wrapped up a busy early-December news cycle. The company closed a multi‑billion‑dollar debt
1 5 6 7 8 9 41
Go toTop